TrialDiabetes care2020

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial.

Hirotaka Watada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.